95 related articles for article (PubMed ID: 22296496)
1. Kinetics of bilirubin and liver enzymes is useful for predicting of liver graft-versus-host disease.
Krejci M; Kamelander J; Pospisil Z; Mayer J
Neoplasma; 2012; 59(3):264-8. PubMed ID: 22296496
[TBL] [Abstract][Full Text] [Related]
2. Hepatitic graft-versus-host disease after hematopoietic stem cell transplantation: clinicopathologic features and prognostic implication.
Ma SY; Au WY; Ng IO; Lie AK; Leung AY; Liang R; Lau GK; Kwong YL
Transplantation; 2004 Apr; 77(8):1252-9. PubMed ID: 15114094
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of acute liver "graft-versus-host disease" following allogeneic myeloablative stem cell transplant].
Doki N; Saito Y; Hatsumi N; Irisawa H; Sakura T; Miyawaki S
Rinsho Ketsueki; 2004 Jan; 45(1):57-60. PubMed ID: 14999935
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors identifiable at the time of onset of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation.
Lee KH; Choi SJ; Lee JH; Lee JS; Kim WK; Lee KB; Sohn SK; Kim JG; Kim DH; Seol M; Lee YS; Lee JH
Haematologica; 2005 Jul; 90(7):939-48. PubMed ID: 15996932
[TBL] [Abstract][Full Text] [Related]
5. [Liver biopsy in the management of liver dysfunction after allogeneic hematopoietic stem-cell transplantation].
Chen H; Huang XJ; Liu KY; Xu LP; Wang H; Liu DH; Lu J; Lu DP
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3062-6. PubMed ID: 16324408
[TBL] [Abstract][Full Text] [Related]
6. Correlation between the kinetics of CD3+ chimerism and the incidence of graft-versus-host disease in patients undergoing allogeneic hematopoietic stem cell transplantation.
Rupa-Matysek J; Lewandowski K; Nowak W; Sawiński K; Gil L; Komarnicki M
Transplant Proc; 2011 Jun; 43(5):1915-23. PubMed ID: 21693300
[TBL] [Abstract][Full Text] [Related]
7. Chronic graft-versus-host disease of the liver: presentation as an acute hepatitis.
Strasser SI; Shulman HM; Flowers ME; Reddy R; Margolis DA; Prumbaum M; Seropian SE; McDonald GB
Hepatology; 2000 Dec; 32(6):1265-71. PubMed ID: 11093733
[TBL] [Abstract][Full Text] [Related]
8. Increased gene expression of chemokine receptors is correlated with acute graft-versus-host disease after allogeneic stem cell transplantation.
Jaksch M; Remberger M; Mattsson J
Biol Blood Marrow Transplant; 2005 Apr; 11(4):280-7. PubMed ID: 15812393
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic transplantation of selected CD34+ cells from peripheral blood: experience of 62 cases using immunoadsorption or immunomagnetic technique. Spanish Group of Allo-PBT.
Urbano-Ispizua A; Solano C; Brunet S; de la Rubia J; Odriozola J; Zuazu J; Figuera A; Caballero D; Martínez C; García J; Sanz G; Torrabadella M; Alegre A; Pérez-Oteiza J; Jurado M; Oyonarte S; Sierra J; García-Conde J; Rozman C
Bone Marrow Transplant; 1998 Sep; 22(6):519-25. PubMed ID: 9758337
[TBL] [Abstract][Full Text] [Related]
10. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
11. Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease.
Bridge AT; Nelson RP; Schwartz JE; Mirowski GW; Billings SD
Am J Dermatopathol; 2007 Feb; 29(1):1-6. PubMed ID: 17284954
[TBL] [Abstract][Full Text] [Related]
12. Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning.
Baron F; Lechanteur C; Willems E; Bruck F; Baudoux E; Seidel L; Vanbellinghen JF; Hafraoui K; Lejeune M; Gothot A; Fillet G; Beguin Y
Biol Blood Marrow Transplant; 2010 Jun; 16(6):838-47. PubMed ID: 20109568
[TBL] [Abstract][Full Text] [Related]
13. Liver graft-versus-host disease after donor lymphocyte infusion for relapses of hematologic malignancies post allogeneic hematopoietic stem cell transplantation.
Ma SY; Au WY; Lie AK; Ng IO; Leung AY; Tse EW; Liang RH; Lau GK; Kwong YL
Bone Marrow Transplant; 2004 Jul; 34(1):57-61. PubMed ID: 15156162
[TBL] [Abstract][Full Text] [Related]
14. Elevation of serum liver enzymes after laparoscopic cholecystectomy.
Sakorafas G; Anagnostopoulos G; Stafyla V; Koletis T; Kotsifopoulos N; Tsiakos S; Kassaras G
N Z Med J; 2005 Feb; 118(1210):U1317. PubMed ID: 15776093
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic stem cell transplantation as treatment for heavily treated, refractory acute graft-versus-host disease after HLA-mismatched stem cell transplantation.
Ikegame K; Yoshihara S; Taniguchi Y; Kaida K; Inoue T; Okada M; Taniguchi K; Hasei H; Tamaki H; Fujioka T; Kato R; Soma T; Ogawa H
Exp Hematol; 2011 Aug; 39(8):880-90. PubMed ID: 21689724
[TBL] [Abstract][Full Text] [Related]
16. Mucositis after allogeneic hematopoietic stem cell transplantation: a cohort study of methotrexate- and non-methotrexate-containing graft-versus-host disease prophylaxis regimens.
Cutler C; Li S; Kim HT; Laglenne P; Szeto KC; Hoffmeister L; Harrison MJ; Ho V; Alyea E; Lee SJ; Soiffer R; Sonis S; Antin JH
Biol Blood Marrow Transplant; 2005 May; 11(5):383-8. PubMed ID: 15846292
[TBL] [Abstract][Full Text] [Related]
17. Serum 5'nucleotidase and alkaline phosphatase--highly predictive liver function tests for the diagnosis of graft-versus-host disease in bone marrow transplant recipients.
Yasmineh WG; Filipovich AH; Killeen AA
Transplantation; 1989 Nov; 48(5):809-14. PubMed ID: 2554545
[TBL] [Abstract][Full Text] [Related]
18. A trend towards an increased incidence of chronic graft-versus-host disease following allogeneic peripheral blood progenitor cell transplantation: a case controlled study.
Scott MA; Gandhi MK; Jestice HK; Mahendra P; Bass G; Marcus RE
Bone Marrow Transplant; 1998 Aug; 22(3):273-6. PubMed ID: 9720741
[TBL] [Abstract][Full Text] [Related]
19. Serum cholinesterase is an early and sensitive marker of graft-versus host-disease (GVHD) and transplant-related mortality (TRM).
Bacigalupo A; Oneto R; Bruno B; Lamparelli T; Gualandi F; Bregante S; Raiola AM; Di Grazia C; Dominietto A; Lombardi A; Frassoni F; Van Lint MT
Bone Marrow Transplant; 2001 Dec; 28(11):1041-5. PubMed ID: 11781614
[TBL] [Abstract][Full Text] [Related]
20. Histologic features of the liver biopsy predict the clinical outcome for patients with graft-versus-host disease of the liver.
Duarte RF; Delgado J; Shaw BE; Wrench DJ; Ethell M; Patch D; Dhillon AP; Mackinnon S; Potter MN; Quaglia AF
Biol Blood Marrow Transplant; 2005 Oct; 11(10):805-13. PubMed ID: 16182181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
